The federal drug discount site has expanded its catalog and delivered steep price cuts for select medications, but is it living up to its promises.
Drugs
Healthcare will keep getting more expensive as more people lose coverage, complicating the rules governing the sector.
Proposed framework would allow Canadian regulator to use drug approval decisions from foreign agencies to speed up approvals in Canada.
Shift to all-electronic PA system could save billions, ease provider burden, and create interoperable healthcare ecosystem for the 21st century, says CMS Administrator Oz.
A new study finds that a process designed to ensure patients receive timely and appropriate care may actually be gumming up the works.
The changes move products containing marijuana to a less restrictive category, taking significant strides toward the legalization of the drug itself.
In a high-stakes struggle over the fate of the popular drug pricing program, neither the Trump administration nor safety-net hospital groups seem willing to cede the field.
A Senate agreement to restart federal operations also introduces a stringent framework for hemp-derived cannabinoid products, with significant implications for compliance teams across a $28-billion sector.